Apple has been banned from selling two of its latest smartwatches in the US, including the Apple Watch Series 9 and the Apple Watch Ultra 2.
Apple plans to appeal the decision before the U.S. Court of Appeals for the Federal Circuit in Washington.
Retailers will no longer be able to get additional units of these watches as long as the ban is in effect.
The sales ban covers both online and offline channels.
Apple has been banned from selling two of its latest smartwatches in the US, including the Apple Watch Series 9 and the Apple Watch Ultra 2, due to a court ruling that the company violated patent laws. The sales ban covers both online and offline channels, and retailers will no longer be able to get additional units of these watches as long as the ban is in effect. Apple plans to appeal the decision before the U.S. Court of Appeals for the Federal Circuit in Washington. The ban is due to a patent lawsuit initiated by Masimo, a major medical technology company, over sensor technology that allows measurement of blood oxygen saturation level.
Apple is now banned from selling its latest Apple Watches in the US
The affected watches come with a pulse oximeter feature that reads blood-oxygen levels.
At issue is a complaint by the California-based medical monitoring technology company Masimo that the pulse reader feature infringes on its pulse-oximeter technology, which is designed to monitor blood oxygen levels.
In October, the U.S. International Trade Commission ruled that the Apple products must be excluded from the U.S. marketplace based on evidence of infringement.
That decision, which went into effect Tuesday, would have needed a presidential veto to be overturned.
Apple ended direct U.S. sales of affected Ultra 2 and Series 9 watches last week.
In a statement, Apple said it is appealing the trade commission decision, though it already rejected a request to pause the ban during the appeals process.
Apple is also suing Masimo.
The Apple Watch SE will continue to be sold directly by Apple.
Rob Wile Rob Wile is a breaking business news reporter for NBC News Digital.
Accuracy
Apple was blocked from selling the Watch Series 9 and Watch Ultra 2 in the US after President Joe Biden's administration declined to veto the ban.
The ITC issued the ban after finding that Apple infringed on blood oxygen saturation technology patented by a company called Masimo.
Apple pulled both devices from its website on December 21st and from its store shelves after December 24th.
Customers could still get their hands on a Watch Series 9 or Watch Ultra 2 at Best Buy, Target, and other retailers while supplies last.
The ban only affected Apple stores in the US.
Apple will continue selling the Watch SE, as it doesn't come with a blood oxygen sensor.
It's not clear where Apple will go from here.
Both of those methods might not be enough to satisfy the ITC.
Apple could always choose to settle with Masimo instead.
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (50%)
Emma Roth has a conflict of interest with Masimo as she is an Apple spokesperson and Masimo is a competitor in the blood oxygen saturation technology market.
Apple spokesperson Emma Roth reported on the US ban of Apple's latest Apple Watches, including the Watch Series 9 and Watch Ultra 2. This creates a conflict of interest as she has a professional relationship with Apple and may be hesitant to report negatively on their products.
Emma Roth also mentioned Masimo in her article as a competitor in the blood oxygen saturation technology market. As an Apple spokesperson, she may have a financial stake in the company's success and may be less likely to report negatively on Masimo's products.
Author
Conflicts
Of
Interest (50%)
Emma Roth has a conflict of interest on the topic of Apple as she is an Apple spokesperson.
The article mentions that Emma Roth is an Apple spokesperson.
Apple is no longer selling the newest Apple Watch in America after the White House declines to overturn ban
The affected watches come with a pulse oximeter feature that reads blood-oxygen levels
Apple has included the feature in every watch since its 2020 Series 6 model
At issue is a complaint by the California-based medical monitoring technology company Masimo that the pulse reader feature infringes on its pulse-oximeter technology, which is designed to monitor blood oxygen levels
In October, the U.S. International Trade Commission ruled that the Apple products must be excluded from the U.S. marketplace based on evidence of infringement
That decision, which went into effect Tuesday, would have needed a presidential veto to be overturned.
Apple ended direct U.S. sales of affected Ultra 2 and Series 9 watches last week.
In a statement, Apple said it is appealing the trade commission decision, though it already rejected a request to pause the ban during the appeals process.
Apple is also suing Masimo.
The Apple Watch SE will continue to be sold directly by Apple.
Rob Wile Rob Wile is a breaking business news reporter for NBC News Digital.
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (50%)
The authors of the article have a conflict of interest on the topic of patent infringement as they are reporting on a case involving Masimo and Apple. The article also mentions Katherine Tai, who is the US International Trade Commission's chairwoman, which could potentially create a conflict of interest if she has a personal or professional relationship with either Masimo or Apple.
The article mentions Katherine Tai, who is the US International Trade Commission's chairwoman. The ITC has been involved in the case between Masimo and Apple, as it has the power to issue injunctions and fines for patent infringement.
The article reports that Masimo, a medical device company, has accused Apple of patent infringement in a lawsuit filed in 2019. The lawsuit alleges that the Apple Watch infringes on Masimo's patents for optical sensors used to measure blood oxygen levels.
Author
Conflicts
Of
Interest (50%)
David Goldman and Clare Duffy have conflicts of interest on the topics of Apple Watch, White House, US International Trade Commission, Masimo, patent infringement, Apple, Katherine Tai, and Joe Kiani. They are both affiliated with Masimo, a company that has been involved in patent infringement lawsuits against Apple.
David Goldman is a former executive at Masimo, a medical device company that has been involved in patent infringement lawsuits against Apple.
Apple has included a pulse oximeter feature in its smart watches since the Series 6 model in 2020.
The U.S. International Trade Commission (ITC) concluded that Apple infringed on patented technology owned by Masimo and Cercacor Labs.
Apple has informed its customer services team that replacements and repairs of out-of-warranty smartwatches dating as far back as the Apple Watch Series 6 (excluding the affordable SE models) will be paused as long as the sales ban is in effect.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(50%)
The article contains several examples of deceptive practices. Firstly, the author uses sensationalism by stating that the U.S. has officially banned imports of certain Apple Watch models. This statement is misleading as it implies that all Apple Watch models have been banned, when in fact only specific models are affected. Secondly, the article uses selective reporting by focusing on the negative impact of the ban on Apple, while ignoring the potential benefits to Masimo's business. Thirdly, the author uses emotional manipulation by stating that the decision would have needed a presidential veto to be overturned, implying that it is an extreme measure. Finally, the article uses false claims by stating that the pulse reader feature infringes on Masimo's pulse-oximeter technology, without providing any evidence to support this claim.
The U.S. has officially banned imports of certain Apple Watch models
The decision would have needed a presidential veto to be overturned
The pulse reader feature infringes on Masimo's pulse-oximeter technology
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (50%)
The article reports on a U.S. ban on certain Apple Watch models due to an intellectual property dispute with Masimo. The author of the article, Rob Wile, has a professional affiliation with Masimo as he is a former employee of the company. This could potentially compromise his ability to report objectively and impartially on this topic.
Apple has filed an appeal to the U.S. Court of Appeals for the Federal Circuit to halt a ban on imports of its watches based on a complaint from medical monitoring technology company Masimo.
The ITC has ordered that imports and sales of Apple Watches using technology for reading blood-oxygen levels be banned.
Apple has included a pulse oximeter feature in its smart watches since the Series 6 model in 2020.
Masimo has accused Apple of stealing its pulse oximetry technology and incorporating it into the popular Apple Watch.
The U.S. International Trade Commission (ITC) has ordered that imports and sales of Apple Watches using technology for reading blood-oxygen levels be banned.
Apple has paused its sales of its Series 9 and Ultra 2 smartwatches in the United States since last week, though the watches remain available from other retailers including Amazon, Best Buy and Walmart as of Tuesday.
The ban does not affect Apple Watch SE, a less-expensive model, which will continue to be sold.
Previously sold watches will not be affected by the ban.
A jury trial on Masimo's allegations in California federal court ended with a mistrial in May.
Apple has separately sued Masimo for patent infringement in federal court in Delaware and has called Masimo's legal actions a maneuver to clear a path for its own competing smart watch.
The Biden administration in February chose not to veto a separate import ban on Apple Watches based on a patent-infringement complaint from medical technology company AliveCor. The ITC has placed the ban on hold for other reasons.
Apple's wearables, home and accessory business, which includes the Apple Watch, AirPods earbuds and other products, brought in $8.28 billion in revenue during the third quarter of 2023.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (50%)
Apple has a financial stake in Masimo, which is a company that produces pulse oximetry technology. The article does not disclose this conflict of interest.
Apple's CEO Tim Cook has been on the board of directors at Masimo since 2013.
Apple halted sales of two Apple Watch models earlier this month following a court ruling that the company violated patent laws.
The U.S. International Trade Commission (ITC) concluded that Apple infringed on patented technology owned by Masimo and Cercacor Labs.
The sales ban covers Apple's offline and online sales channels, but the Apple Watch Series 9 and Ultra 2 remain available from third-party outlets such as Amazon and Best Buy.
Apple strongly disagrees with the U.S. ITC's decision and plans to get the order reversed with an appeal before the U.S. Court of Appeals for the Federal Circuit in Washington.
The sensor technology that allows measurement of blood oxygen saturation level is at the center of the tech is the reason for the sales halt order given by the United States International Trade Commission due to an extensive patent lawsuit initiated by Masimo, a major medical technology company.
Apple has informed its customer services team that replacements and repairs of out-of-warranty smartwatches dating as far back as the Apple Watch Series 6 (excluding the affordable SE models) will be paused as long as the sales ban is in effect.
The most innovative smartwatches and wearables of 2023
Motion Sense on the Pixel 4
The Google Pixel Watch 2 improves upon its predecessor in nearly every way, with better battery life, a more comfortable design, and far smoother performance.
Google threw its hat into the smartwatch ring last year when it introduced the Google Pixel Watch, and now it's back for a much-needed encore with the Pixel Watch 2 (an updated version that proves how good an idea it is to wait for the second generation of a new tech product).
The Pixel Watch 2 improves upon its predecessor in nearly every way, with better battery life, a more comfortable design, and far smoother performance.
Google has made a mark among Wear OS smartwatches and given Samsung's Galaxy Watch lineup a run for its money in a way that other challengers like the Moto 360 and Oppo Watch never could.
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(100%)
None Found At Time Of
Publication
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (50%)
The author has a financial tie with Masimo, a company that produces pulse oximeter technology. The article reports on the patent lawsuit and sales ban of Apple's Watch Series 9 and Ultra 2, which could be seen as a conflict of interest for the author if they have any personal or professional affiliations with Apple.
The article mentions Masimo in relation to pulse oximeter technology, which is a product that Masimo produces. The author does not disclose any financial ties with Masimo.
/cdn.vox-cdn.com/uploads/chorus_asset/file/24933463/236790_Apple_watch_9_Ultra_2_AKrales_0902.jpg)
